Innoscripta SE: Founders to Support Share Price with Selective Purchases

In a strategic move to bolster investor confidence, the founders of Innoscripta SE have announced their intention to make selective share purchases. This decision comes as the company’s stock has recently hit its 52-week low of €86.3 on June 15, 2025, a significant drop from its 52-week high of €120 on May 22, 2025. The announcement was made on June 17, 2025, by the company’s primary shareholders, Michael Hohenester and Alexander Meyer, through their respective investment vehicles, Hohenester Beteiligungs-UG and Meyer Beteiligungs-UG.

The planned acquisition involves a total volume of up to €12 million, with €10 million allocated from Hohenester Beteiligungs-UG and €2 million from Meyer Beteiligungs-UG. This move is aimed at providing stability and support to the share price, reflecting the founders’ commitment to the company’s long-term success.

Innoscripta SE, listed on the Frankfurt Stock Exchange, operates in a competitive market, and this strategic intervention by its founders is a clear signal of their confidence in the company’s future prospects. The close price of the stock on June 15, 2025, was €86.3, and the founders’ actions are expected to positively influence market perception and investor sentiment.

Autodoc SE’s IPO: A Major Event in Frankfurt

In related financial news, Autodoc SE, a leading digital platform for automotive parts in Europe, is set to make a significant impact on the Frankfurt Stock Exchange with its initial public offering (IPO). The company has announced a price range of €58 to €61 per share for its planned private placement, aiming to raise substantial capital. This move is expected to result in a market capitalization of approximately €2.4 billion at the upper end of the price range.

Apollo Global Management Inc., a key backer of Autodoc SE, had previously invested €2.3 billion in the company. The IPO, scheduled for June 25, 2025, marks a pivotal moment for Autodoc SE as it transitions to a publicly traded entity. The listing is anticipated to attract significant attention, given the company’s strong market position and the substantial capital being raised.

The IPO of Autodoc SE is part of a broader trend of European companies seeking public listings, highlighting the dynamic nature of the region’s financial markets. As Innoscripta SE’s founders take steps to stabilize their company’s stock, Autodoc SE’s upcoming IPO underscores the vibrant activity and opportunities within the European financial landscape.

These developments reflect the strategic maneuvers by key players in the market, aiming to capitalize on growth opportunities and enhance shareholder value. Investors and market watchers will be keenly observing the outcomes of these initiatives as they unfold.